11:47 AM EST, 03/03/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Monday that it has officially launched Galzin, which is approved by the US Food and Drug Administration for the maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent.

The company said Galzin capsules are exclusively available through specialty pharmacy Optime Care.

Shares of the company fell 2.4% in recent trading.

Price: 15.32, Change: -0.38, Percent Change: -2.42